Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

384
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
384
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

643
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
643
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

813
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
813
Drug Therapy01:28

Drug Therapy

107
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
107
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

250
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
250
Depressants01:28

Depressants

186
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
186

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence is king: A defence of evidence-based recommendations.

Bipolar disorders·2022
Same author

Longitudinal maturation of resting state networks: Relevance to sustained attention and attention deficit/hyperactivity disorder.

Cognitive, affective & behavioral neuroscience·2022
Same author

Debate: Inpatient units must enhance the system of care.

Child and adolescent mental health·2021
Same author

The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: Major depression summary.

Bipolar disorders·2020
Same author

The 2020 Royal Australian and New Zealand College of psychiatrists clinical practice guidelines for mood disorders: Bipolar disorder summary.

Bipolar disorders·2020
Same author

Video Consultation Consumer Home-based Assessment Tool (VC-CHAT).

The Australian and New Zealand journal of psychiatry·2020
Same journal

Dual antihypertensive fixed-dose combinations approved for first-line use on the Pharmaceutical Benefits Scheme.

Australian prescriber·2026
Same journal

Capivasertib for locally advanced or metastatic breast cancer.

Australian prescriber·2026
Same journal

Diagnosis and management of irritable bowel syndrome.

Australian prescriber·2026
Same journal

Stopping antidepressants: when and how.

Australian prescriber·2026
Same journal

Emergency contraception: an overview.

Australian prescriber·2026
Same journal

Sodium valproate: balancing benefits and risks especially in people of childbearing potential.

Australian prescriber·2026
See all related articles

Related Experiment Video

Updated: Sep 22, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

198

Antidepressants in adolescence.

Phillip Hazell

    Australian Prescriber
    |May 20, 2022
    PubMed
    Summary
    This summary is machine-generated.

    Antidepressants are used for adolescent anxiety, obsessive compulsive disorder, and major depressive disorder. Response varies, necessitating psychiatric consultation and monitoring for adverse effects like suicidality.

    Keywords:
    adolescentantidepressive drugsanxiety disordersdepressive disorderobsessive compulsive disorder

    More Related Videos

    The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
    07:13

    The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

    Published on: October 24, 2018

    17.8K
    Author Spotlight: Understanding Adolescent Social Adversity Effects on Neurodevelopment in Mice
    07:15

    Author Spotlight: Understanding Adolescent Social Adversity Effects on Neurodevelopment in Mice

    Published on: March 15, 2024

    1.8K

    Related Experiment Videos

    Last Updated: Sep 22, 2025

    Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
    08:15

    Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

    Published on: June 6, 2025

    198
    The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
    07:13

    The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

    Published on: October 24, 2018

    17.8K
    Author Spotlight: Understanding Adolescent Social Adversity Effects on Neurodevelopment in Mice
    07:15

    Author Spotlight: Understanding Adolescent Social Adversity Effects on Neurodevelopment in Mice

    Published on: March 15, 2024

    1.8K

    Area of Science:

    • Psychiatry
    • Adolescent Medicine
    • Pharmacology

    Background:

    • Antidepressants are considered for adolescent anxiety, obsessive compulsive disorder (OCD), and major depressive disorder (MDD).
    • They serve as second-line treatments for anxiety and OCD, and potentially first- or second-line for severe MDD.
    • Treatment efficacy varies across these conditions.

    Purpose of the Study:

    • To summarize the role and effectiveness of antidepressants in adolescent mental health conditions.
    • To outline treatment guidelines, including referral criteria and monitoring for adverse events.

    Main Methods:

    • Review of current clinical guidelines and evidence regarding antidepressant use in adolescents.
    • Analysis of treatment response rates and adverse effect profiles for specific conditions.

    Main Results:

    • Antidepressant response is generally good for anxiety and OCD, but less convincing for MDD in adolescents.
    • Referral for psychiatric opinion is recommended for non-responders after an adequate antidepressant trial.
    • Rare but serious adverse effects, including suicide-related behaviors, mania, and serotonin syndrome, require vigilant monitoring.

    Conclusions:

    • Antidepressants have a defined role in adolescent mental health treatment, particularly for anxiety and OCD.
    • Careful patient selection, monitoring, and timely psychiatric referral are crucial for optimizing outcomes and ensuring safety.
    • The effectiveness of antidepressants in adolescent MDD warrants further investigation and careful consideration.